Generics Bulletin is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Entering The GGB Awards: One Week To Go!

Still Time To Submit Entries Ahead Of 9 October Ceremony In Milan

Executive Summary

An additional week has been added to the deadline for companies to submit their entries for the Global Generics & Biosimilars Awards 2024, ahead of our ceremony in Milan on 9 October.

One more week remains for entrants to submit their achievements to the Global Generics & Biosimilars Awards 2024, after the entry deadline was extended to 29 July.

Entries must be submitted by 29 July at the latest. They can cover any activities undertaken between 1 September 2023 and 31 July 2024.

Once the entries have been evaluated by our panel of independent expert judges and the winners selected, our prizegiving ceremony will then take place at the Hotel NH Milano Fiera on Wednesday 9 October, during CPhI Worldwide week.

For more details on the event, Generics Bulletin editors Dave Wallace and Dean Rudge recently recorded a podcast talking about how companies can enter and attend the awards – both of which remain free of charge – as well as offering tips for prospective entrants and exploring the reasons why off-patent industry players might want to be involved in the awards (see sidebar).

Backed by our headline sponsor IQVIA, category sponsors for the awards also include Adalvo in the Active Pharmaceutical Ingredient supplier of the Year category, Cerba Research for Company of the Year – Americas, as well as Pharmacloud for our Leader of the Year category.

The awards are also supported by International Health Partners in our corporate social responsibility initiative of the year category. Our 2024 supporters also include the International Generic and Biosimilars Medicines Association, as well as the US Association for Accessible Medicines and its Biosimilars Council.

Other categories will include our company of the year award and our two other regional company of the year awards for the Asia-Pacific and EMEA regions; acquisition of the year; biosimilar initiative of the year; and business development of the year.

Meanwhile, further awards will recognize the best campaign of the year; the leading industry partner; regulatory achievement of the year; and value added medicine initiative of the year.

For a full list of the awards categories, submissions criteria, how to attend and other information, go here.

To enquire about sponsorship opportunities, please e-mail [email protected]

And to register interest in attending the Global Generics & Biosimilars Awards 2024, to receive the latest updates and for any further details, please e-mail [email protected]

 

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

GB153654

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel